 |
|
|
   
|
Extensive scientific testing proves Obagi Nu-Derm System Healthy Skin Protection
SPF 35 is an effective UVA/UVB sunscreen
LONG BEACH, Calif., Oct. 26, 2004 - Obagi Medical Products (OMP, Inc.) announced
today that its Obagi Nu-Derm System Healthy Skin Protection SPF 35 sunscreen has
won the Skin Cancer Foundation's "Seal of Recommendation." The Skin Cancer
Foundation awarded its Seal of Recommendation based on its own analyses of
scientific tests. The analyses concluded that Obagi Nu-Derm Healthy Skin
Protection SPF 35 effectively prevents sun-induced skin damage by screening out
UVA and UVB exposure. To qualify for the Seal, the sunscreen had to meet
stringent criteria and high standards set by the Foundation's Photobiology
Committee.
By combining highly effective physical sun filters, 9% zinc oxide and 7.5% octyl
methoxycinnamate, Obagi Nu-Derm System Healthy Skin Protection SPF 35 delivers
broad-spectrum protection against irreversible damage from the sun's harmful UVA
and UVB rays. This sunscreen is suitable for adult skin and children over 6
months of age. The Foundation stated that when used regularly, Obagi's Healthy
Skin Protection SPF 35 also helps reduce the risk for skin cancer due to
overexposure to sunlight.
Based in Long Beach, CA, Obagi Medical Products develops, manufactures, markets
and sells the leading brand of physician monitored and dispensed skin care
products in the United States. Obagi's presence extends beyond the U.S. into
Japan, Scandinavia, Europe, Canada, Mexico and Central America, Latin America,
the Middle East, and Southeast Asia. For more information or to locate a
physician in your area, go to www.obagi.com, or call 1-800-636-7546.
For more information contact:
Janice Kenig
Obagi Medical Products
|
|
|
|